Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Identification of hepatitis B virus genotype A/E recombinants in Ghana.

Boyce CL, Willis S, Archampong TNA, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Kwara A, Blackard JT.

Virus Genes. 2019 Jul 25. doi: 10.1007/s11262-019-01690-y. [Epub ahead of print]

PMID:
31346975
2.

Characterisation of protease resistance mutations in a South African paediatric cohort with virological failure, 2011 - 2017.

Makatini Z, Mda S, Towobola O, Mthiyane H, Miles P, Blackard JT.

S Afr Med J. 2019 Jun 28;109(7):511-515. doi: 10.7196/SAMJ.2019.v109i7.13705.

PMID:
31266578
3.

Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis.

Baxter C, Ngcapu S, Blackard JT, Powell EA, Penton PK, Abdool Karim SS.

Viruses. 2019 Jun 19;11(6). pii: E569. doi: 10.3390/v11060569.

4.

Synthetic opioid use and common injection-associated viruses:expanding the translational research agenda.

Blackard JT, Brown JL, Lyons MS.

Curr HIV Res. 2019 Jun 18. doi: 10.2174/1570162X17666190618154534. [Epub ahead of print]

PMID:
31210115
5.

Tips for a Successful Global Health Sabbatical.

Blackard JT.

Ann Glob Health. 2019 May 9;85(1). pii: 66. doi: 10.5334/aogh.724.

PMID:
31074600
6.

Zika virus replication and cytopathic effects in liver cells.

Sherman KE, Rouster SD, Kong LX, Aliota MT, Blackard JT, Dean GE.

PLoS One. 2019 Mar 20;14(3):e0214016. doi: 10.1371/journal.pone.0214016. eCollection 2019.

7.

Molecular characterization of hepatitis B virus in blood donors in Botswana.

Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S.

Virus Genes. 2019 Feb;55(1):33-42. doi: 10.1007/s11262-018-1610-z. Epub 2018 Oct 31.

PMID:
30382563
8.

Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade.

Sherman KE, Abdel-Hameed E, Rouster SD, Shata MTM, Blackard JT, Safaie P, Kroner B, Preiss L, Horn PS, Kottilil S.

Clin Infect Dis. 2019 May 17;68(11):1911-1918. doi: 10.1093/cid/ciy807.

PMID:
30239650
9.

Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Sep 7;9(9). pii: E453. doi: 10.3390/genes9090453.

10.

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Aug 21;9(9). pii: E420. doi: 10.3390/genes9090420.

11.

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.

Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, Lockman S, Gaseitsiwe S.

Genes (Basel). 2018 May 17;9(5). pii: E259. doi: 10.3390/genes9050259.

12.

Zika Virus Exposure in an HIV-Infected Cohort in Ghana.

Sherman KE, Rouster SD, Kong LX, Shata TM, Archampong T, Kwara A, Aliota MT, Blackard JT.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):e35-e38. doi: 10.1097/QAI.0000000000001718. No abstract available.

13.

Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).

Blackard JT, Sherman KE.

Rev Med Virol. 2018 Jul;28(4):e1984. doi: 10.1002/rmv.1984. Epub 2018 May 15. Review.

14.

Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

N'Guessan KF, Boyce C, Kwara A, Archampong TNA, Lartey M, Sagoe KW, Kenu E, Obo-Akwa A, Blackard JT.

Virus Genes. 2018 Jun;54(3):361-367. doi: 10.1007/s11262-018-1555-2. Epub 2018 Mar 17.

15.

Molecular characterization of hepatitis B virus X gene in HIV-positive South Africans.

Gededzha MP, Sondlane TH, Malinga LA, Burnett RJ, Lebelo RL, Blackard JT, Mphahlele MJ, Selabe SG.

Virus Genes. 2018 Apr;54(2):190-198. doi: 10.1007/s11262-018-1536-5. Epub 2018 Feb 6.

PMID:
29411271
16.

A preliminary analysis of hepatitis C virus in pancreatic islet cells.

Blackard JT, Kong L, Lombardi A, Homann D, Hammerstad SS, Tomer Y.

Virol J. 2017 Dec 20;14(1):237. doi: 10.1186/s12985-017-0905-3.

17.

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana.

N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Oct 10;4(4):ofx222. doi: 10.1093/ofid/ofx222. eCollection 2017 Fall.

18.

Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.

Bari K, Luckett K, Kaiser T, Diwan T, Cuffy M, Schoech MR, Safdar K, Blackard JT, Apewokin S, Paterno F, Sherman KE, Zucker SD, Anwar N, Shah SA.

Hepatology. 2018 May;67(5):1673-1682. doi: 10.1002/hep.29704. Epub 2018 Mar 26.

PMID:
29205441
19.

Human pegivirus (HPgV) infection in sub-Saharan Africa-A call for a renewed research agenda.

Singh S, Blackard JT.

Rev Med Virol. 2017 Nov;27(6). doi: 10.1002/rmv.1951. Epub 2017 Nov 17.

PMID:
29148108
20.

Response to: Comment on: Essential competencies in global health research for medical trainees: A narrative review.

White MT, Satterfield CA, Blackard JT.

Med Teach. 2018 Mar;40(3):319-320. doi: 10.1080/0142159X.2017.1392676. Epub 2017 Oct 24. No abstract available.

PMID:
29065745
21.

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana.

Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Sep 13;4(4):ofx195. doi: 10.1093/ofid/ofx195. eCollection 2017 Fall.

22.

Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India.

Saha D, Pal A, Sarkar N, Das D, Blackard JT, Guha SK, Saha B, Chakravarty R.

PLoS One. 2017 Jun 7;12(6):e0179035. doi: 10.1371/journal.pone.0179035. eCollection 2017.

23.

Identification and comparative analysis of hepatitis B virus genotype D/E recombinants in Africa.

Boyce CL, Ganova-Raeva L, Archampong TNA, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Kwara A, Blackard JT.

Virus Genes. 2017 Aug;53(4):538-547. doi: 10.1007/s11262-017-1469-4. Epub 2017 May 31.

24.

Essential competencies in global health research for medical trainees: A narrative review.

White MT, Satterfield CA, Blackard JT.

Med Teach. 2017 Sep;39(9):945-953. doi: 10.1080/0142159X.2017.1324139. Epub 2017 May 14. Review.

PMID:
28504028
25.

Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV.

Blackard JT, Ma G, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, King CC.

J Med Virol. 2017 Nov;89(11):1904-1911. doi: 10.1002/jmv.24836. Epub 2017 Aug 28.

26.

Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.

Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM.

Open Forum Infect Dis. 2016 Aug 16;3(3):ofw140. eCollection 2016 Sep.

27.

Demographics of Hepatitis C in Southwest Ohio (2010 to 2015).

Woltmann J, Burke P, Brady R, Blackard JT.

Hepat Mon. 2016 Jul 20;16(8):e37904. eCollection 2016 Aug.

28.

Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study.

Amponsah-Dacosta E, Rakgole JN, Gededzha MP, Lukhwareni A, Blackard JT, Selabe SG, Mphahlele MJ.

Infect Genet Evol. 2016 Sep;43:232-8. doi: 10.1016/j.meegid.2016.05.035. Epub 2016 May 28.

PMID:
27245151
29.

HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.

Archampong TN, Boyce CL, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Blackard JT, Kwara A.

Antivir Ther. 2017;22(1):13-20. doi: 10.3851/IMP3055. Epub 2016 May 11.

30.

Occult Hepatitis B Virus Infection in a Previously Vaccinated Injection Drug User.

Powell EA, Razeghi S, Zucker S, Blackard JT.

Hepat Mon. 2016 Feb 20;16(2):e34758. doi: 10.5812/hepatmon.34758. eCollection 2016 Feb.

31.

Recombination among GB virus C (GBV-C) isolates in the United States.

Blackard JT, Ma G, Polen C, DuBois JC, Gast J, Radens CM, Sterling RK, Sherman KE.

J Gen Virol. 2016 Jul;97(7):1537-44. doi: 10.1099/jgv.0.000477. Epub 2016 Apr 11.

32.

Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Powell EA, Boyce CL, Gededzha MP, Selabe SG, Mphahlele MJ, Blackard JT.

J Gen Virol. 2016 Jul;97(7):1615-24. doi: 10.1099/jgv.0.000469. Epub 2016 Mar 31.

33.

Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa.

Prabdial-Sing N, Blackard JT, Puren AJ, Mahomed A, Abuelhassan W, Mahlangu J, Vermeulen M, Bowyer SM.

Antiviral Res. 2016 Mar;127:90-8. doi: 10.1016/j.antiviral.2015.11.011. Epub 2015 Dec 17.

PMID:
26704023
34.

Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana.

Anderson M, Gaseitsiwe S, Moyo S, Wessels MJ, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM.

BMC Infect Dis. 2015 Aug 13;15:335. doi: 10.1186/s12879-015-1096-4.

35.

Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants.

Amponsah-Dacosta E, Lebelo RL, Rakgole JN, Selabe SG, Gededzha MP, Mayaphi SH, Powell EA, Blackard JT, Mphahlele MJ.

J Clin Virol. 2015 Feb;63:12-7. doi: 10.1016/j.jcv.2014.11.032. Epub 2014 Dec 3.

36.

GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection.

Blackard JT, Ma G, Welge JA, King CC, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, Gardner L.

PLoS One. 2014 Dec 10;9(12):e114467. doi: 10.1371/journal.pone.0114467. eCollection 2014.

37.

Mutations associated with occult hepatitis B in HIV-positive South Africans.

Powell EA, Gededzha MP, Rentz M, Rakgole NJ, Selabe SG, Seleise TA, Mphahlele MJ, Blackard JT.

J Med Virol. 2015 Mar;87(3):388-400. doi: 10.1002/jmv.24057. Epub 2014 Aug 27.

38.

Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.

Sherman KE, Guedj J, Shata MT, Blackard JT, Rouster SD, Castro M, Feinberg J, Sterling RK, Goodman Z, Aronow BJ, Perelson AS.

Sci Transl Med. 2014 Jul 23;6(246):246ra98. doi: 10.1126/scitranslmed.3008195.

39.

Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.

Blackard JT, Ma G, Sengupta S, Martin CM, Powell EA, Shata MT, Sherman KE.

J Med Virol. 2014 Aug;86(8):1332-41. doi: 10.1002/jmv.23968. Epub 2014 Apr 30.

40.

HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitro.

Kong L, Welge JA, Powell EA, Blackard JT.

PLoS One. 2014 Feb 28;9(2):e83728. doi: 10.1371/journal.pone.0083728. eCollection 2014.

41.

Near full-length genome analysis of HCV genotype 5 strains from South Africa.

Gededzha MP, Selabe SG, Blackard JT, Kyaw T, Mphahlele MJ.

Infect Genet Evol. 2014 Jan;21:118-23. doi: 10.1016/j.meegid.2013.10.022. Epub 2013 Nov 9.

PMID:
24220189
42.

Analysis of HIV quasispecies suggests compartmentalization in the liver.

Penton PK, Blackard JT.

AIDS Res Hum Retroviruses. 2014 Apr;30(4):394-402. doi: 10.1089/AID.2013.0146. Epub 2013 Oct 25.

43.

Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV.

Mayaphi SH, Martin DJ, Mphahlele MJ, Blackard JT, Bowyer SM.

J Med Virol. 2013 Nov;85(11):1883-92. doi: 10.1002/jmv.23695. Epub 2013 Aug 7.

44.

Effects of HCV on basal and tat-induced HIV LTR activation.

Sengupta S, Powell E, Kong L, Blackard JT.

PLoS One. 2013 Jun 10;8(6):e64956. doi: 10.1371/journal.pone.0064956. Print 2013.

45.

Interferon alfa partially inhibits HIV replication in hepatocytes in vitro.

Kong L, Blackard JT.

J Infect Dis. 2013 Sep 1;208(5):865-6. doi: 10.1093/infdis/jit255. Epub 2013 Jun 10. No abstract available.

PMID:
23757338
46.

Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis.

Blackard JT, Kong L, Huber AK, Tomer Y.

Thyroid. 2013 Jul;23(7):863-70. doi: 10.1089/thy.2012.0507. Epub 2013 Jun 21.

47.

HCV superinfection and reinfection.

Blackard JT.

Antivir Ther. 2012;17(7 Pt B):1443-8. doi: 10.3851/IMP2460. Epub 2012 Dec 7. Review.

PMID:
23221168
48.

Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.

Martin CM, Welge JA, Rouster SD, Shata MT, Sherman KE, Blackard JT.

J Viral Hepat. 2012 Oct;19(10):716-23. doi: 10.1111/j.1365-2893.2012.01595.x. Epub 2012 Jun 4.

49.

Limited infection with occult hepatitis B virus in drug users in the USA.

Blackard JT, Martin CM, Sengupta S, Forrester J.

Hepatol Res. 2013 Apr;43(4):413-7. doi: 10.1111/j.1872-034X.2012.01072.x. Epub 2012 Aug 22.

50.

Low-level HIV infection of hepatocytes.

Kong L, Cardona Maya W, Moreno-Fernandez ME, Ma G, Shata MT, Sherman KE, Chougnet C, Blackard JT.

Virol J. 2012 Aug 9;9:157. doi: 10.1186/1743-422X-9-157.

Supplemental Content

Loading ...
Support Center